Dr. Yutong Zhao's lab at Ohio State University focuses on understanding the mechanisms of acute inflammatory diseases and idiopathic pulmonary fibrosis (IPF). The team investigates how specific proteins regulate cell metabolism, inflammation, and fibrosis in the lungs. By studying these processes, they aim to identify new therapeutic strategies to treat conditions like sepsis and lung injuries.

Dr. Rizwan Ahmad's lab at Ohio State University focuses on advancing cardiac imaging techniques to improve the diagnosis and treatment of heart valve diseases, particularly mitral valve regurgitation. The team is developing a new MRI protocol that enhances the speed and accuracy of blood flow measurements within the heart, aiming to enable better clinical decisions for patients with heart conditions. This research has the potential to significantly improve patient outcomes by providing more precise assessments compared to current methods.

Dr. Stephen David Bell's lab focuses on studying archaeal microorganisms to better understand fundamental biological processes that are also present in more complex eukaryotic cells. By investigating how archaea organize their DNA and manage gene expression, the lab aims to uncover parallels to eukaryotic systems, offering insights into evolution and essential molecular functions. Their work has significant implications for understanding the basic mechanisms of life.

Dr. Xun Ai's lab at Ohio State University focuses on understanding the molecular mechanisms behind atrial fibrillation (AF), particularly how alcohol consumption and inflammation contribute to this common heart condition. The research aims to identify new therapeutic targets and biomarkers related to AF, especially in the context of postoperative scenarios and alcohol-induced heart damage. Through a combination of electrophysiological techniques and biochemical assays, the lab seeks to establish a novel understanding of the interactions between stress-response pathways and inflammation in AF pathogenesis.

Dr. Glen N. Barber's lab at Ohio State University studies how a protein called STING plays a key role in the immune system, particularly regarding how our bodies respond to infections and cancer. They focus on understanding the mechanisms by which STING signaling can make infected or damaged cells more recognizable to the immune system, potentially improving cancer treatment strategies. The lab's work has implications for developing more effective therapies for various health issues, including cancer and inflammatory diseases.

Dr. Anil V Parwani's lab at Ohio State University focuses on cancer research through the collection and management of human biospecimens. They work as part of a cooperative network that provides high-quality biological samples to researchers, enabling groundbreaking studies in cancer treatment and personalized medicine. Their work supports a better understanding of cancer biology and helps develop new therapies based on human tissues and clinical data.

Dr. Ming-Chen Hsu’s lab at Iowa State University focuses on improving heart valve disease treatments through advanced computer modeling and machine learning. They develop a digital twin technology that simulates how heart valves work to help doctors personalize interventions for patients. The goal is to enhance treatment effectiveness, make healthcare more efficient, and improve patients' quality of life.

Dr. Thippeswamy's lab focuses on developing new treatments to help people recover from nerve agent poisoning, which can cause severe, long-lasting neurotoxic effects. The research aims to explore the effectiveness of two novel drugs in preventing and reversing brain damage and cognitive impairments caused by exposure to chemical warfare nerve agents. By testing these therapies in animal models, the lab aims to improve medical countermeasures for victims exposed to these harmful agents.

Maria Schweer-Collins' lab focuses on improving the lives of youth in foster care, particularly by preventing substance use issues. The lab is working on adapting and implementing a program called the CASA Brief Intervention, designed to educate and support these young people through trained advocates. By leveraging existing community services and focusing on tailored interventions, the lab aims to create effective and scalable solutions for this vulnerable population.

Dr. Kai Xu's lab at Ohio State University focuses on understanding henipaviruses, which can be deadly and have potential for future pandemics. The research aims to study the surface proteins of these viruses to develop better vaccines and treatments. This work is vital as henipaviruses can transfer between animals and humans, leading to serious outbreaks.

Dr. Jian Zhu's lab at Ohio State University focuses on understanding how HIV persists in the body, particularly in the brain, and how factors like drug use influence this persistence. They explore the role of host genes and epigenetic regulation in keeping HIV dormant and investigate potential therapies by repurposing existing FDA-approved drugs. By studying how drugs like cocaine affect gene expression related to HIV, the lab aims to develop strategies for effective treatments.

Dr. Jing Zhao's lab at Ohio State University is focused on understanding how certain proteins regulate the immune response during severe bacterial infections. They study the role of a specialized protein complex called the immunoproteasome, particularly how it contributes to inflammation and tissue damage in conditions like pneumonia and sepsis. The goal is to identify new targets for therapies that can help control harmful inflammation and improve patient outcomes.

Dr. Jianrong Li's research lab focuses on developing innovative vaccines for gastrointestinal and respiratory viruses. One major project aims to create mucosal vaccines for norovirus, targeting a global health issue where no effective vaccines currently exist. Another project investigates RNA modifications in SARS-CoV-2, which could lead to improved treatments and vaccines against COVID-19. The lab combines advanced viral vector technology with cutting-edge genetic research to address critical public health challenges.

Dr. Xiaoguang Margaret Liu's lab at Ohio State University focuses on developing innovative treatment strategies for triple-negative breast cancers (TNBCs), which are known for their aggressive nature and poor response to conventional therapies. By combining immunotherapy with novel drug delivery systems and gene therapies, the lab aims to improve cancer treatment efficacy and reduce recurrence rates. Key areas of research include antibody-drug conjugates and mitochondrial gene therapy, both designed to engage the immune system while directly targeting cancer cells.

Dr. Xue Han's lab at Ohio State University focuses on understanding how the immune system is regulated in lupus, an autoimmune disease. The lab is investigating a specific protein called PD-1H that plays a crucial role in controlling immune responses in tissues affected by lupus. By studying how PD-1H functions, the lab aims to develop new therapies that can better manage lupus and improve patients' health.

Dr. Chen Gu's lab at Ohio State University focuses on understanding how certain ion channels influence both the immune response and neuron function in the central nervous system (CNS). By studying the interactions between T cells and neurons, particularly in conditions like multiple sclerosis, the lab aims to identify new strategies for neuroprotection and repair that could help address inflammatory demyelinating disorders. They employ a variety of advanced techniques to delve into these complex biological processes.

The Poirier lab at Ohio State University focuses on understanding how chromatin structure influences gene expression. They employ a variety of experimental techniques to explore the roles of chromatin regulators, such as histones and transcription factors, in making DNA accessible for transcription. Their research aims to elucidate how specific proteins, known as pioneer transcription factors, navigate complex chromatin environments, and how epigenetic modifications can regulate these processes. By uncovering these molecular mechanisms, the lab hopes to shed light on important aspects of cell differentiation and cancer biology.

Dr. Harpreet Singh's lab at Ohio State University focuses on understanding the roles of specific potassium channels in heart and cell function, particularly in relation to exosomes and mitochondria. The team investigates how these channels can affect heart health, including preventing damage during conditions like ischemia. Their research may lead to new therapies for heart disease by exploring the potential of exosomal channels in drug delivery and cardiac protection.

Dr. Nuo Sun's lab focuses on understanding how mitochondrial health affects heart function as we age. They study processes called mitophagy and neddylation to see how the heart can maintain good mitochondrial quality and how these processes can be targeted for new treatments for heart diseases, particularly in regard to aging and metabolic changes. By using innovative mouse models and advanced genetic techniques, the lab aims to discover new insights into heart health and dysfunction.

Dr. Andrea Tedeschi's lab at Ohio State University researches how spinal cord injuries (SCI) affect fat tissue and metabolism. They aim to understand the mechanisms behind fat tissue dysfunction and how it contributes to weight gain and metabolic problems, like insulin resistance, after SCI. The lab studies the roles of nerves that interact with fat cells and seeks to find ways to improve health outcomes for individuals with SCI.